Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The state of disparities in opportunistic infection prophylaxis for blacks with HIV/AIDS.

Oramasionwu CU, Koeller JM, Lawson KA, Brown CM, Morse GD, Frei CR.

Med Care. 2012 Nov;50(11):920-7. doi: 10.1097/MLR.0b013e31826c85d1. Review.

2.

Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature.

Palacio H, Kahn JG, Richards TA, Morin SF.

Public Health Rep. 2002 May-Jun;117(3):233-51; discussion 231-2. Review.

3.

Evaluating HIV/AIDS disparities for blacks in the United States: a review of antiretroviral and mortality studies.

Oramasionwu CU, Brown CM, Lawson KA, Ryan L, Frei CR.

J Natl Med Assoc. 2009 Dec;101(12):1221-9. Review.

PMID:
20070010
4.

Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J.

MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22.

PMID:
12412613
5.

High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.

Gebo KA, Fleishman JA, Reilly ED, Moore RD; HIV Research Network.

Med Care. 2005 Sep;43(9 Suppl):III23-30.

PMID:
16116306
6.

Racial differences in the use of drug therapy for HIV disease in an urban community.

Moore RD, Stanton D, Gopalan R, Chaisson RE.

N Engl J Med. 1994 Mar 17;330(11):763-8.

7.

Cardiovascular Disease in Blacks with HIV/AIDS in the United States: A Systematic Review of the Literature.

Oramasionwu CU, Hunter JM, Brown CM, Morse GD, Lawson KA, Koeller JM, Frei CR.

Open AIDS J. 2012;6:29-35. doi: 10.2174/1874613601206010029. Epub 2012 Apr 26.

8.

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R; Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics.

MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166.

9.

Disparities in Consistent Retention in HIV Care--11 States and the District of Columbia, 2011-2013.

Dasgupta S, Oster AM, Li J, Hall HI.

MMWR Morb Mortal Wkly Rep. 2016 Feb 5;65(4):77-82. doi: 10.15585/mmwr.mm6504a2.

10.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
11.

Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.

Sackoff J, McFarland J, Su S, Bryan E.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):387-92.

PMID:
9833748
12.

Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.

Detels R, Tarwater P, Phair JP, Margolick J, Riddler SA, Muñoz A; Multicenter AIDS Cohort Study.

AIDS. 2001 Feb 16;15(3):347-55.

PMID:
11273215
13.

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD.

JAMA. 1998 Jan 14;279(2):130-6. Erratum in: JAMA 1999 Jun 2;281(21):1989.

PMID:
9440663
14.

Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study.

Oramasionwu CU, Hunter JM, Skinner J, Ryan L, Lawson KA, Brown CM, Makos BR, Frei CR.

BMC Infect Dis. 2009 Aug 11;9:127. doi: 10.1186/1471-2334-9-127.

15.

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.

Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, Kaslow RA.

N Engl J Med. 1993 Dec 23;329(26):1922-6.

16.

Disparities in diagnoses of HIV infection between blacks/African Americans and other racial/ethnic populations--37 states, 2005-2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):93-8.

17.

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.

Soriano V, Dona C, Rodríguez-Rosado R, Barreiro P, González-Lahoz J.

AIDS. 2000 Mar 10;14(4):383-6.

PMID:
10770540
18.

Mortality among blacks or African Americans with HIV infection--United States, 2008-2012.

Siddiqi AE, Hu X, Hall HI; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):81-6. Erratum in: MMWR Morb Mortal Wkly Rep. 2015 Feb 20;64(6):159.

19.

Racial/ethnic disparities among children with diagnoses of perinatal HIV infection - 34 states, 2004-2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Feb 5;59(4):97-101. Erratum in: MMWR Morb Mortal Wkly Rep. 2010 Feb 12;59(5):136.

20.

HIV/AIDS disparities: the mounting epidemic plaguing US blacks.

Oramasionwu CU, Brown CM, Ryan L, Lawson KA, Hunter JM, Frei CR.

J Natl Med Assoc. 2009 Dec;101(12):1196-204. Review.

PMID:
20070007
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk